This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
A first-in-class drug for NASH? Resmetirom, an oral, liver-targeting, once-daily THR-β-selective agonist, recently made headlines for meeting both primary surrogate…
molecule
8 months ago ●
5 mins read
Drug Hunter’s April 2022 edition of Molecules of the Month features some emerging small molecule clinical candidates as well as…
Article
1 year ago ●
1 min read
What is it? RMC-5552 is a potential first-in-class, bi-steric, mTOR1-selective inhibitor in Ph. I/IIb (NCT04774952, NCT05557292) as an IV agent…
molecule
8 months ago ●
3 mins read
Thank you to all of the drug hunters who attended our second drug discovery webinar! You can find the video…
Article
1 year ago ●
1 min read
What is it? Inavolisib is a PI3Kα isoform-selective kinase inhibitor and monovalent degrader of the mutant p110α catalytic subunit of…
molecule
8 months ago ●
5 mins read
The FDA in 2021 approved four novel small molecule drugs for various infectious diseases, including human immunodeficiency virus type-1 (HIV-1),…
Article
1 year ago ●
12 mins read
Load More
